Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 8.93
-0.02 (-0.22%)
Sep 15, 2026, 1:42 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 560.59 million as of September 15, 2026. Its market cap has decreased by -69.87% in one year.
Market Cap
560.59M
Enterprise Value
401.16M
Revenue
408.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.93
ChartMarket Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 560.59M, a decrease of -71.19%. That is a compound annual growth rate of -31.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 858.99M | -40.28% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.07B |
| Bio Preventive Medicine | 1.04B |
| Level Biotechnology | 1.02B |
| TCI GENE | 947.21M |
| GeneReach Biotechnology | 926.79M |
| NatureWise Biotech & Medicals | 867.37M |
| Neith | 793.51M |
| Lukas Biomedical | 766.30M |